1. Greenspon AJ, Patel JD, Lau E, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011; 58:1001–1006. PMID:
21867833.
2. Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010; 121:458–477. PMID:
20048212.
3. Mela T, McGovern BA, Garan H, et al. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter- defibrillator implants. Am J Cardiol. 2001; 88:750–753. PMID:
11589841.
4. Uslan DZ, Sohail MR, St Sauver JL, et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch Intern Med. 2007; 167:669–675. PMID:
17420425.
5. Yang PS, Jeong J, You SJ, et al. The burden and risk factors for infection of transvenous cardiovascular implantable electronic device: a nationwide cohort study. Korean Circ J. 2019; 49:742–752. PMID:
31074228.
6. Poole JE, Gleva MJ, Mela T, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010; 122:1553–1561. PMID:
20921437.
7. Krahn AD, Longtin Y, Philippon F, et al. Prevention of arrhythmia device infection trial: the PADIT trial. J Am Coll Cardiol. 2018; 72:3098–3109. PMID:
30545448.
8. Kleemann T, Becker T, Strauss M, et al. Prevalence of bacterial colonization of generator pockets in implantable cardioverter defibrillator patients without signs of infection undergoing generator replacement or lead revision. Europace. 2010; 12:58–63. PMID:
19861383.
9. Lakkireddy D, Pillarisetti J, Atkins D, et al. IMpact of pocKet rEvision on the rate of InfecTion and other CompLications in patients rEquiring pocket mAnipulation for generator replacement and/or lead replacement or revisioN (MAKE IT CLEAN): a prospective randomized study. Heart Rhythm. 2015; 12:950–956. PMID:
25625720.
10. Deering TF, Chang C, Snyder C, Natarajan SK, Matheny R. Enhanced antimicrobial effects of decellularized extracellular matrix (CorMatrix) with added vancomycin and gentamicin for device implant protection. Pacing Clin Electrophysiol. 2017; 40:615–623. PMID:
28240419.
11. Tarakji MG, Mittal S, Kennergren C, et al. Antibacterial envelope to prevent cardiac implantable device infection. N Engl J Med. 2019.